Answers are grounded in this paper and cite their sources.
Objective To compare real‑time synchronous aspiration‑guided radiofrequency ablation (RFA) with conventional staged aspiration‑followed‑by‑RFA for patients with predominantly cystic thyroid nodules (PCTNs).Materials and methods Ninety‑eight patients with 102 PCTNs who underwent RFA were retrospectively enrolled, including 52 patients (54 nodules) in the real‑time aspiration group and 46 patients (48 nodules) in the conventional group. The volume reduction ratio (VRR), procedural parameters, treatment success rate, cyst‑fluid reaccumulation rate, and complication rate were compared between the two groups.Results Baseline characteristics were comparable between groups (all p > 0.05). The technical success rate was 100% in both groups. The real‑time aspiration group obtained significantly higher VRR at postoperative day 1 (51.2% vs. 24.8%), 6‑month follow‑up (96.8% vs. 87.3%), and 12‑month follow‑up (98.1% vs. 91.4%; all p < 0.001). This group also demonstrated shorter procedure time (24.3 vs. 33.5 min, p < 0.001), fewer RFA electrode insertions (1.2 vs. 2.9, p < 0.001), lower overall complication rate (5.8% vs. 28.3%, p < 0.001), higher 12‑month treatment success rate (98.1% vs. 85.4%), and lower cyst‑fluid reaccumulation rate (1.9% vs. 12.5%, p = 0.038).Conclusion Real‑time aspiration‑integrated RFA provides superior nodule volume reduction, procedural efficiency, and safety for PCTNs. Prospective multicenter studies are warranted to validate its long‑term efficacy.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: